acaciadiv20190214_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): February 14, 2019

 

Acacia Diversified Holdings, Inc.

(Exact Name of Registrant as Specified in Its Charter)

                           

Texas

1-14088

75-2095676

(State or Other Jurisdiction of Incorporation) 

 (Commission File Number) 

 (I.R.S. Employer Identification No.)

 

13575 58th Street North - #138 Clearwater, FL 33760

(Address of Principal Executive Offices)

 

(727) 678-4420

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (§240.12b-2 of this chapter)

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

 

 

Forward-Looking Statements

Statements in this Current Report on Form 8-K may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Acacia, MariJ Pharmaceuticals, Inc. or Eufloria Medical of Tennessee, Inc. or websites does not constitute a part of this Current Report.

 

 

Section 8 – Other Events

 

Item 8.01 Other Events

 

Acacia Diversified Holdings, Inc. ("Acacia" or the "Company") (OTCQB symbol: ACCA), an emerging industrial hemp company, is announcing its partnership with Tennessee State University (“TSU”) for potentially groundbreaking hemp research.

 

Dr. Ying Wu, Associate Professor of Food and Animal Science at the College of Agriculture of TSU, has begun working on investigation of phytochemical profiles in hemp seeds, oils and extracts, and their related health benefits. The goal is to develop some health promoting product using the cutting-edge technologies and provide reliable data of nutrients and phytochemicals in different hemp varieties. Eufloria Medical of Tennessee, Inc. (Eufloria), is a wholly-owned subsidiary of the Company and will be manufacturing material for the university study. Eufloria is a vertically-integrated hemp operation, a unique model of operations in Tennessee.

 

The research partnership will seek to create a whole-plant encapsulation method that would be used in both food and drink. The Company aims to create a safe and chemical-free vehicle to obtain the health benefits of the whole-hemp plant into virtually anything from food and beverages to topical creams. The TSU research could produce innovative ways to obtain whole plant extract.

 

About the Company:

 

Acacia Diversified Holdings has a wholly-owned subsidiary for growing hemp called Eufloria and it uses its processing and manufacturing company, MariJ to create consumer products for distribution under the Eufloria brand. Dahlia’s Botanicals is another part of the Acacia portfolio, with a portion of sales from its U.S.D.A Certified Organic Hemp product going to the Cannamoms organization.

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

Acacia Diversified Holdings, Inc.

 

 

Date: February 14, 2019

/s/ Richard K. Pertile

  

 

Richard K. Pertile, Chief Executive Officer